Shuji Izumo
About
Shuji Izumo is a scholar working on Immunology, Agronomy and Crop Science and Ecology, Evolution, Behavior and Systematics.
According to data from OpenAlex, Shuji Izumo has authored 179 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Immunology, 75 papers in Agronomy and Crop Science and 67 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in Shuji Izumo's work include T-cell and Retrovirus Studies (122 papers), Animal Disease Management and Epidemiology (75 papers) and Vector-Borne Animal Diseases (67 papers). Shuji Izumo is often cited by papers focused on T-cell and Retrovirus Studies (122 papers), Animal Disease Management and Epidemiology (75 papers) and Vector-Borne Animal Diseases (67 papers). Shuji Izumo collaborates with scholars based in Japan, United States and United Kingdom. Shuji Izumo's co-authors include Mitsuhiro Osame, Koichiro Usuku, Fujio Umehara, Ryuji Kubota, Masanori Nakagawa, Masahiro Nagai, Kimiyoshi Arimura, Norihiro Takenouchi, Charles R. M. Bangham and Mitsutoshi Tara and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The EMBO Journal and Blood.
In The Last Decade
Shuji Izumo
178 papers receiving 6.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Shuji Izumo Japan | 42 | 5.1k | 3.3k | 3.0k | 849 | 492 | 179 | 6.6k | ||
| Ichiro Miyoshi Japan | 39 | 3.4k 0.7× | 2.5k 0.8× | 2.4k 0.8× | 1.5k 1.8× | 260 0.5× | 162 | 6.1k | ||
| Fujio Umehara Japan | 31 | 1.0k 0.2× | 511 0.2× | 542 0.2× | 752 0.9× | 467 0.9× | 102 | 2.6k | ||
| Yoshihisa Yamano Japan | 30 | 2.3k 0.5× | 1.4k 0.4× | 1.3k 0.4× | 294 0.3× | 46 0.1× | 177 | 3.1k | ||
| Tsutomu Miyamoto Japan | 36 | 1.0k 0.2× | 638 0.2× | 555 0.2× | 1.4k 1.7× | 51 0.1× | 144 | 3.9k | ||
| Mitsuo Maruyama Japan | 25 | 2.4k 0.5× | 355 0.1× | 302 0.1× | 2.1k 2.5× | 61 0.1× | 61 | 4.7k | ||
| J R Rusche United States | 18 | 1.1k 0.2× | 182 0.1× | 98 0.0× | 937 1.1× | 107 0.2× | 25 | 2.9k | ||
| Parham A. Ganchi United States | 16 | 1.0k 0.2× | 174 0.1× | 134 0.0× | 735 0.9× | 54 0.1× | 20 | 2.1k | ||
| An Billiau Belgium | 31 | 1.6k 0.3× | 90 0.0× | 69 0.0× | 592 0.7× | 101 0.2× | 82 | 3.1k | ||
| Ryuichi Wada Japan | 20 | 385 0.1× | 102 0.0× | 116 0.0× | 1.8k 2.2× | 190 0.4× | 89 | 3.0k | ||
| Carmen Sánchez‐Torres Mexico | 28 | 1.7k 0.3× | 139 0.0× | 80 0.0× | 614 0.7× | 54 0.1× | 63 | 2.7k |
Countries citing papers authored by Shuji Izumo
Since
Specialization
Citations
This map shows the geographic impact of Shuji Izumo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuji Izumo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuji Izumo more than expected).
Fields of papers citing papers by Shuji Izumo
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Shuji Izumo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuji Izumo. The network helps show where Shuji Izumo may publish in the future.
Co-authorship network of co-authors of Shuji Izumo
This figure shows the co-authorship network connecting the top 25 collaborators of Shuji Izumo. A scholar is included among the top collaborators of Shuji Izumo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuji Izumo. Shuji Izumo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Kodama, Daisuke, Masakazu Tanaka, Toshio Matsuzaki, et al.. (2021). Anti-Human T-Cell Leukemia Virus Type 1 (HTLV-1) Antibody Assays in Cerebrospinal Fluid for the Diagnosis of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis. Journal of Clinical Microbiology. 59(5).
2.
Sato, Tomoo, Ariella Coler‐Reilly, Atae Utsunomiya, et al.. (2013). CSF CXCL10, CXCL9, and Neopterin as Candidate Prognostic Biomarkers for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis. PLoS neglected tropical diseases. 7(10). e2479–e2479.
3.
Kozako, Tomohiro, Masaki Akimoto, Shingo Toji, et al.. (2011). Target epitopes of HTLV‐1 recognized by class I MHC‐restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders. Journal of Medical Virology. 83(3). 501–509.
4.
Kasai, Takefumi, Hiroshi Shirahama, Takayuki Suetsugu, et al.. (2009). CD8 positive T-cell infiltration in the dentate nucleus of paraneoplastic cerebellar degeneration. Journal of Neuroimmunology. 208(1-2). 136–140.
5.
Xing, Hui, et al.. (2008). Impaired Astrocytes and Diffuse Activation of Microglia in the Cerebral Cortex in Simian Immunodeficiency Virus-Infected Macaques Without Simian Immunodeficiency Virus Encephalitis. Journal of Neuropathology & Experimental Neurology. 67(6). 600–611.
6.
Yukitake, Motohiro, Eisaburo Sueoka, Naoko Sueoka‐Aragane, et al.. (2008). Significantly increased antibody response to heterogeneous nuclear ribonucleoproteins in cerebrospinal fluid of multiple sclerosis patients but not in patients with human T-lymphotropic virus type I–associated myelopathy/tropical spastic paraparesis. Journal of NeuroVirology. 14(2). 130–135.
7.
Furukawa, Yoshitaka, Koichiro Usuku, Shuji Izumo, & Mitsuhiro Osame. (2004). Human T Cell Lymphotropic Virus Type I (HTLV-I) p12 I Is Dispensable for HTLV-I Transmission and Maintenance of Infection in Vivo. AIDS Research and Human Retroviruses. 20(10). 1092–1099.
8.
Saito, Mineki, Masanori Nakagawa, Toshio Matsuzaki, et al.. (2004). Decreased Human T Lymphotropic Virus Type I (HTLV‐I) Provirus Load and Alteration in T Cell Phenotype after Interferon‐α Therapy for HTLV‐I–Associated Myelopathy/Tropical Spastic Paraparesis. The Journal of Infectious Diseases. 189(1). 29–40.
9.
Takenouchi, Norihiro, Yoshihisa Yamano, Koichiro Usuku, Mitsuhiro Osame, & Shuji Izumo. (2003). Usefulness of Proviral Load Measurement for Monitoring of Disease Activity in Individual Patients with Human T-Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis. Journal of NeuroVirology. 9(1). 29–35.
10.
Umehara, Fujio, et al.. (2002). Involvement of Fas/Fas ligand system in the spinal cords of HTLV-I-associated myelopathy. Acta Neuropathologica. 103(4). 384–390.
11.
Jeffery, Katie, Asna A. Siddiqui, Mike Bunce, et al.. (2000). The Influence of HLA Class I Alleles and Heterozygosity on the Outcome of Human T Cell Lymphotropic Virus Type I Infection. The Journal of Immunology. 165(12). 7278–7284.
12.
Kitze, B., K. Usuku, Shinji Yashiki, et al.. (1996). Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis. Acta Neurologica Scandinavica. 94(4). 287–293.
13.
Ijichi, Shinji, Masanori Nakagawa, Fujio Umehara, et al.. (1996). HAM/TSP: Recent Perspectives in Japan. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 13. S26–S32.
14.
Ijichi, Shinji, Shuji Izumo, Masahiro Nagai, et al.. (1995). Anti-viral and immunomodulatory effects of interferon-α on cultured lymphocytes from patients with human T lymphotropic virus type I-associated myelopathy (HAM/TSP). Journal of Neuroimmunology. 61(2). 213–221.
15.
Lehky, Tanya, Michael C. Levin, Steven Jacobson, et al.. (1995). Detection of human T‐lymphotropic virus type I (HTLV‐I) tax RNA in the central nervous system of HTLV‐I–associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Annals of Neurology. 37(2). 167–175.
16.
Nakagawa, Masanori, Shuji Izumo, Shinji Ijichi, et al.. (1995). HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. Journal of NeuroVirology. 1(1). 50–61.
17.
Saito, Mineki, Yoshitaka Furukawa, Ryuji Kubota, et al.. (1995). Frequent mutation in pX region of HTLV-1 is observed in HAM/TSP patients, but is not specifically associated with the central nervous system lesions. Journal of NeuroVirology. 1(3-4). 286–294.
18.
Matsumuro, Kenji, Shuji Izumo, Fujio Umehara, et al.. (1994). Paraneoplastic vasculitic neuropathy: immunohistochemical studies on a biopsied nerve and post‐mortem examination. Journal of Internal Medicine. 236(2). 225–230.
19.
Umehara, Fujio, Shuji Izumo, Masanori Nakagawa, et al.. (1993). Immunocytochemical Analysis of the Cellular Infiltrate in the Spinal Cord Lesions in HTLV-I-Associated Myelopathy. Journal of Neuropathology & Experimental Neurology. 52(4). 424–430.
20.
Ohara, Yoshikazu, Y. Iwasaki, Shuji Izumo, I Kobayashi, & Akira Yoshioka. (1992). Search for human T-cell leukemia virus type I (HTLV-I) proviral sequences by polymerase chain reaction in the central nervous system tissue of HTLV-I-associated myelopathy. Archives of Virology. 124(1-2). 31–43.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Ichiro Miyoshi Breakdown of academic impact, for papers by Fujio Umehara Breakdown of academic impact, for papers by Yoshihisa Yamano Breakdown of academic impact, for papers by Tsutomu Miyamoto Breakdown of academic impact, for papers by Mitsuo Maruyama Breakdown of academic impact, for papers by J R Rusche Breakdown of academic impact, for papers by Parham A. Ganchi Breakdown of academic impact, for papers by An Billiau Breakdown of academic impact, for papers by Ryuichi Wada Breakdown of academic impact, for papers by Carmen Sánchez‐Torres